Can a cycle-tracking app work as birth control? The evidence, honestly
In a 22,785-user study of one temperature-based app, typical use failed 6.9 per 100 woman-years and perfect use 1.0 — but the study came from the maker, and traditional methods vary widely.
A cycle-tracking app used strictly as a fertility-awareness method can prevent pregnancy at rates comparable to other user-dependent methods — but only under strict use, and the best-published numbers come from a study the app's own makers conducted [s1]. The broader evidence on fertility-awareness methods is thin and uneven, with real-world failure rates that vary widely from one method and study to the next [s2]. That is the honest state of the question, and it matters because "period tracker" and "birth control" are not the same claim.
Most popular cycle apps are not contraceptives at all; they predict periods and ovulation windows for planning. A small number are designed and marketed as contraception, using logged data to tell a couple which days require a barrier method or abstinence. The evidence below concerns that second, narrower category.
What the app study found
The most-cited study of a contraceptive app followed 22,785 users of Natural Cycles, a method that combines the dates of menstruation with daily basal body temperature to flag fertile and infertile days [s1]. Users logged a total of 18,548 woman-years of data, which the researchers used to calculate Pearl Indexes — pregnancies per 100 woman-years of use [s1].
Typical use produced a Pearl Index of 6.9 pregnancies per 100 woman-years (95% CI 6.5-7.2), and the study estimated a 13-cycle typical-use failure rate of 8.3% [s1]. Perfect use — following the app's guidance every cycle — gave a Pearl Index of 1.0 (95% CI 0.5-1.5) [s1]. The rate of pregnancies traceable to the algorithm itself wrongly flagging a fertile day as infertile was 0.5 per 100 woman-years [s1]. The authors concluded the app's efficacy is "higher than usually reported for traditional fertility awareness-based methods" [s1].
Two numbers in the same study temper that pitch. The gap between the 1.0 perfect-use and 6.9 typical-use Pearl Index shows how much depends on the user acting on the app's warnings [s1]. And the discontinuation rate over 12 months was 54% — more than half of users stopped within a year [s1].
The conflict that has to be stated
This study cannot be read like an independent trial. Its author list includes the app's co-founders, and the corresponding author's affiliation is the company itself [s1]. That does not make the numbers wrong, but it places them in the category of manufacturer-reported evidence, where independent replication matters more than usual — the same standard this newspaper applies to a drug company's own trial of its own product.
What the independent evidence says about the wider method
Fertility-awareness methods as a class have a weaker evidence base than the app study alone suggests. A systematic review in Obstetrics & Gynecology set out to summarise the best prospective data on typical- and perfect-use effectiveness across specific methods [s2]. Of 53 studies it examined, it rated none high quality — 21 were moderate and 32 low [s2].
Among the moderate-quality studies, first-year typical-use pregnancy rates varied widely between methods, and the reviewers' overall conclusion was blunt: studies on the effectiveness of each fertility-awareness method "are few and of low to moderate quality" [s2]. For the Standard Days Method, moderate-quality studies put first-year typical-use pregnancy rates at 11.2 to 14.1 per 100 woman-years and perfect use at 4.8 [s2]. The point of the review is not any single figure but the spread: a method's published effectiveness depends heavily on which study, which population and which teaching you look at [s2].
What this leaves a reader with
A dedicated contraceptive app, used strictly, performs in the range of other user-dependent methods, and better than older fertility-awareness techniques in its maker's own data [s1]. Used loosely — days skipped, warnings ignored — it performs like the typical-use figure, and half of users abandon it within a year [s1]. The independent literature on fertility awareness as a whole remains limited and of modest quality [s2]. None of this speaks to a general period-tracking app, which makes no contraceptive claim and should not be treated as one.
This article is informational and is not medical advice. Anyone considering a fertility-awareness method or app for contraception should discuss its demands and its failure rates with a clinician.
Sources
- Perfect-use and typical-use Pearl Index of a contraceptive mobile app — Contraception, 2017-09-04
- Effectiveness of Fertility Awareness-Based Methods for Pregnancy Prevention: A Systematic Review — Obstetrics & Gynecology, 2018-09-01
Sources
- Perfect-use and typical-use Pearl Index of a contraceptive mobile app — Contraception , September 4, 2017
- Effectiveness of Fertility Awareness-Based Methods for Pregnancy Prevention: A Systematic Review — Obstetrics & Gynecology , September 1, 2018
The morning-after pill works less well the later you take it — and at higher weight
Trials put the pregnancy rate after emergency contraceptive pills at roughly 1-3%. But the risk rose more than threefold in obese women, and the levonorgestrel pill fared worst of all.
The birth control failure rate on the box is the best case, not your case
The numbers most methods advertise are perfect-use figures from clinical trials. In everyday use the pill fails about seven users in 100 a year, the condom about 13, withdrawal about 20.
Endometriosis has no disease-modifying cure. Every treatment targets the symptoms
Hormones, surgery and painkillers can reduce pain and improve fertility, but none reliably alter the disease itself — and even removing the uterus does not guarantee the disease goes with it.
What actually manages PCOS, according to the international guideline
The 2023 global guideline puts lifestyle first for everyone, letrozole first for fertility, and the pill for cycles and excess hair — while rating much of its own evidence low to moderate quality.